Safety and effectiveness of primary prevention cardioverter defibrillators in octogenarians

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 7, 2011, Pages 900-906

  Strimel, William ^a   Koplik, Sheri ^a   Robert Chen, H ^a   Song, Juhee ^b   Huang, Shoei K Stephen ^a,b  

^a Division of Cardiology   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Cardioverter defibrillator; Octogenarian; Sudden cardiac death

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL STUDY; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE INFECTION; DEVICE SAFETY; DEVICE THERAPY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TAMPONADE; HEMATOMA; HEMATOTHORAX; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NONISCHEMIC CARDIOMYOPATHY; PNEUMOTHORAX; PRIMARY PREVENTION; SUDDEN DEATH; SURVIVAL RATE; THERAPY EFFECT;

AGED, 80 AND OVER; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PRIMARY PREVENTION; RETROSPECTIVE STUDIES;

EID: 84860390396     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03082.x     Document Type: Article

References (16)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannon DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883. (Pubitemid 34984635)
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005;352:225-237. (Pubitemid 40110811)
3. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, III, Freedman RA, Gettes LS, Gillinov AM, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-e62. (Pubitemid 351689050)
4. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrilators for the prevention of mortality in patients with nonischemic cardiomyopathy: A meta-analysis of randomized controlled trials. JAMA 2004;292:2874-2879. (Pubitemid 39628235)
5. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
6. Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Moriilo CA, et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J 2007;28:1746-1749. (Pubitemid 47227082)
7. Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, et al. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: A MADIT II substudy. J Cardiovasc Electrophysiol 2007;18:833-838. (Pubitemid 47093069)
8. Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ. Implantable cardiac device procedures in older patients: Use and in-hospital outcomes. Arch Intern Med 2010;170:631-637.
9. Daniels JD, Saunders J, Parvathaneni S, Byrd A, Joglar JA, Obel O. Electrocardiographic findings, device therapies, and comorbidities in octogenarian implantable defibrillator recipients. J Cardiovsc Electrophysiol 2010;21:236-241.
10. Tang ASL, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-2395.
11. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberrger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549. (Pubitemid 40517094)
12. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002;162:1682-1688.
13. Lee DS, Tu JV, Austin, PC, Dorian P, Yee R, Chong A, Alter DA, et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol 2007;49:2408-2415. (Pubitemid 46962260)
14. Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, Chow T. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes 2009;2:16-24.
15. Noseworthy PA, Lashevsky I, Dorian P, Greene M, Cvitkovic S, Newman D. Feasibility of implantable cardioverter-defibrillator use in elderly patients: A case series of octogenarians. Pacing Clin Electrophysiol 2004;27:373-378. (Pubitemid 38352520)
16. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, Kay GN, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (cieds) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010;7:1008-1026.